WASHINGTON: The anti-malarial drug hydroxychloroquine will be used in a trial covering 3,000 patients at a hospital in Detroit, Michigan, and the results will be tracked in a formal study,
WASHINGTON: The anti-malarial drug hydroxychloroquine will be used in a trial covering 3,000 patients at a hospital in Detroit, Michigan, and the results will be tracked in a formal study,